S. Shenoy

发表

End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.

M. Gladwin, J. Makani, D. E. Bauer, 2019, Blood advances.

Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant Consortium.

Allen R. Chen, M. Cairo, E. Horwitz, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Kyle M. Hebert, B. George, V. Mathews, 2019, Blood advances.

Hematopoietic stem cell transplantation for sickle cell disease: Progress and challenges

S. Shenoy, M. Hulbert, 2018, Pediatric blood & cancer.

Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning.

S. Davies, A. Filipovich, J. Dalal, 2007, Blood.

Has stem cell transplantation come of age in the treatment of sickle cell disease?

S. Shenoy, Shalini Shenoy, 2007, Bone Marrow Transplantation.

Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.

M. Aljurf, M. Horowitz, R. Gale, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Severe sickle cell disease--pathophysiology and therapy.

E. Vichinsky, L. Krishnamurti, S. Shenoy, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous and Allogeneic Hematopoietic Cell Transplantation for Diffuse Large B-cell Lymphoma-Type Richter Syndrome.

C. Jacobson, Q. Bashir, Z. DeFilipp, 2021, Blood advances.

Antibodies to 70 kD and 90 kD heat shock proteins are associated with graft‐versus‐host disease in peripheral blood stem cell transplant recipients

T. Mohanakumar, S. Shenoy, J. Góral, 2002, Clinical and experimental immunology.

Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions

S. Shenoy, 2013, Therapeutic advances in hematology.

Hematopoietic stem cell transplantation for sickle cell disease: current practice and emerging trends.

S. Shenoy, 2011, Hematology. American Society of Hematology. Education Program.

How I treat sickle cell disease with hematopoietic cell transplantation.

L. Krishnamurti, S. Shenoy, Elizabeth Stenger, 2019, Blood.

The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation (HCT): Defining the Unique Late Effects of Children undergoing HCT for Immune Deficiencies, Inherited Marrow Failure Disorders, and Hemogl

P. Rosenberg, J Wagner, L. Notarangelo, 2017 .

Cytolytic T lymphocytes from human renal allograft biopsies are tissue specific.

T. Howard, T. Mohanakumar, M. W. Flye, 1995, Human immunology.

Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation

M. Norkin, S. Choi, M. Qayed, 2021, Blood advances.

Hematopoietic stem cell transplantation for childhood malignancies of myeloid origin

F. Smith, S. Shenoy, 2008, Bone Marrow Transplantation.

Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients.

M. Schnitzler, T. Howard, D. Brennan, 1997, Transplantation.

CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease

S. Shenoy, H. Rangarajan, Alison S. Towerman, 2022, Bone Marrow Transplantation.

Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: graft-versus-host disease and transplant-related mortality.

R. Vij, J. Dipersio, D. Adkins, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immune reconstitution following allogeneic peripheral blood stem cell transplants

J. Dipersio, T. Mohanakumar, D. Adkins, 1999, Bone Marrow Transplantation.

Principles of alemtuzumab immunoablation in hematopoietic cell transplantation for non‐malignant diseases in children: A review

S. Shenoy, G. Guilcher, R. Shah, 2018, Pediatric transplantation.

Defective apoptosis in lymphocytes and the role of IL-2 in autoimmune hematologic cytopenias.

T. Chatila, J. Tersak, T. Mohanakumar, 2001, Clinical immunology.

Light Microscopic, Immunophenotypic, and Molecular Genetic Study of Autoimmune Lymphoproliferative Syndrome Caused by fas Mutation

J. Hess, T. Chatila, S. Shenoy, 2000, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

Light Microscopic, Immunophenotypic, and Molecular Genetic Study of Autoimmune Lymphoproliferative Syndrome Caused by fas Mutation:

J. Hess, T. Chatila, S. Shenoy, 2000 .

Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study

L. Meacham, K. Syrjala, B. Shaw, 2022, JMIR research protocols.

A Multicenter Retrospective Analysis Stressing the Importance of Long-Term Follow-Up after Hematopoietic Cell Transplantation for β-Thalassemia.

M. Ayas, A. Thompson, M. Bhatia, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Peripheral blood microchimerism in human liver and renal transplant recipients: rejection despite donor-specific chimerism.

T. Howard, T. Mohanakumar, D. Brennan, 1997, Transplantation.

Functional and Radiologic Assessment of the Brain after Reduced-Intensity Unrelated Donor Transplantation for Severe Sickle Cell Disease—Blood and Marrow Transplant Clinical Trials Network #0601 Blood Marrow

R. McKinstry, M. Eapen, S. Shenoy, 2019 .

E. Neufeld, F. Trachtenberg, A. Thompson, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.

E. Neufeld, P. Bierling, J. Bussel, 2012, Blood.

reduced intensity conditioning Successful bone marrow transplantation for IPEX syndrome following

S. Davies, A. Filipovich, J. Dalal, 2013 .

B. George, V. Mathews, C. Dvorak, 2018, Blood advances.

Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias

W. Grossman, S. Shenoy, A. Rao, 2008, Pediatric blood & cancer.

A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients.

M. Schnitzler, T. Howard, D. Brennan, 1999, Transplantation.

Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy.

T. Howard, D. Brennan, G. Storch, 1997, Journal of the American Society of Nephrology : JASN.

Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies.

S. Pai, C. Bollard, M. Pulsipher, 2018, Blood.

Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.

P. Rosenberg, H. Deeg, J. Tolar, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immune Responses to Collagen‐IV and Fibronectin in Renal Transplant Recipients With Transplant Glomerulopathy

W. Chapman, T. Mohanakumar, J. Gaut, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease

S. Shenoy, H. Rangarajan, Alison S. Towerman, 2022, Bone Marrow Transplantation.

Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myeloid Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular Therapy.

M. Sulis, J. Chewning, S. Meshinchi, 2022, Transplantation and cellular therapy.

Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation.

R. Vij, D. Adkins, L. Goodnough, 2000, Blood.

Evidence of a role for matrix metalloproteinases in cold preservation injury of the liver in humans and in the rat

T. Howard, S. Strasberg, S. Shenoy, 1997, Hepatology.

Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman–Diamond syndrome

T. Smolarek, S. Davies, S. Jodele, 2008, Bone Marrow Transplantation.

Acquired monosomy 7 myelodysplastic syndrome in a child with clinical features suggestive of dyskeratosis congenita and IMAGe association

S. Kulkarni, T. Ferkol, David B. Wilson, 2010, Pediatric blood & cancer.

Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies

A. King, G. Cuvelier, N. Bunin, 2015, American journal of hematology.

Umbilical cord blood as a hematopoietic stem cell source in transplantation for pediatric sickle cell disease: Current challenges and strategies.

S. Shenoy, M. Malhotra, 2022, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Relationship between Mixed Donor-Recipient Chimerism and Disease Recurrence after Hematopoietic Cell Transplantation for Sickle Cell Disease.

J. Tisdale, M. Hsieh, M. Eapen, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sickle cell disease

S. Shenoy, S. Chaudhury, 2017 .

Umbilical Cord Blood: An Evolving Stem Cell Source for Sickle Cell Disease Transplants

S. Shenoy, 2013, Stem cells translational medicine.

S. Spellman, J. Panepinto, B. Logan, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

D. Jacobsohn, S. Shenoy, David C. Delgado, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Defining the Unique Late Effects of Children Undergoing Hematopoietic Cell Transplantation for Immune Deficiencies, Inherited Marrow Fail

P. Rosenberg, J. Wagner, L. Notarangelo, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Functional and Radiologic Assessment of the Brain after Reduced-Intensity Unrelated Donor Transplantation for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network Study 0601.

R. McKinstry, A. King, Juan Wu, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Granulocyte–colony‐stimulating factor–mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage

R. Vij, K. Trinkaus, J. Dipersio, 2006, Transfusion.

Mercury poisoning associated with high-dose hepatitis-B immune globulin administration after liver transplantation for chronic hepatitis B.

T. Howard, M. Peters, S. Shenoy, 1996, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Excellent Outcomes Following Hematopoietic Cell Transplantation for Wiskott-Aldrich Syndrome: A PIDTC Report.

L. Notarangelo, H. Ochs, J. Puck, 2020, Blood.

Pretransplant dobutamine stress echocardiography is useful and cost-effective in renal transplant candidates.

T. Howard, D. Brennan, G. Singer, 1997, Transplantation proceedings.

Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease

Bryon D Johnson, J. Verbsky, M. Cairo, 2022, Frontiers in Immunology.

Liver transplantation after jejunoileal bypass for morbid obesity.

T. Howard, M. Peters, C. Caldwell, 1997, Journal of the American College of Surgeons.

Exposure of early pediatric trainees to blood and marrow transplantation leads to higher recruitment to the field.

A. Bracey, E. Nemecek, M. Pulsipher, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic Cell Transplantation for Congenital Dyserythropoietic Anemia. A Report from the Pediatric Transplant and Cellular Therapy Consortium (PTCTC).

M. Pulsipher, J. Stanek, D. Buchbinder, 2022, Transplantation and cellular therapy.

Awareness of cord blood collection and the impact on banking

Aleksandar Babic, S. Shenoy, D. Bhatla, 2017, Pediatric blood & cancer.

Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD

M. Norkin, S. Furlan, M. Pasquini, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease.

D. Jacobsohn, S. Shenoy, M. Hulbert, 2020, Blood advances.

Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression.

Allen R. Chen, S. Meshinchi, M. Loken, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results.

J. Varni, W. Tse, M. Horowitz, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

P. Hari, J. Varni, W. Tse, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation (HCT) in Hurler's syndrome using a reduced intensity preparative regimen

S. Davies, P. Mehta, S. Jodele, 2008, Bone Marrow Transplantation.

Robust Donor Chimerism and Engraftment Following Familial Haploidentical (FHI) (CD34 Enriched and T-Cell Addback) Allogeneic Stem Cell Transplantation in Patients with High Risk Sickle Cell Disease (SCD)

M. Cairo, L. Baxter‐Lowe, T. Moore, 2016 .

A Multicenter Phase II Trial of Unrelated Donor Reduced Intensity Bone Marrow Transplantation for Children with Severe Sickle Cell Disease (SCURT): Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0601) Study

Juan Wu, B. Logan, M. Eapen, 2015 .

Chimerism in the Realm of Hematopoietic Stem Cell Transplantation for Non-malignant Disorders—A Perspective

S. Shenoy, Clare Zimmerman, 2020, Frontiers in Immunology.

Hematopoietic Stem Cell Transplantation: A Neonatal Perspective.

S. Shenoy, E. Hall, 2019, NeoReviews.

A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders

J. Dipersio, W. Grossman, T. Mohanakumar, 2005, Bone Marrow Transplantation.

Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome

D. Sillence, B. Burton, J. Abdenur, 2005, Genetics in Medicine.

Late Toxicity of a Novel Allogeneic Stem Cell Transplant Using Single Fraction Total Body Irradiation for Hematologic Malignancies in Children

T. Druley, S. Shenoy, R. Hayashi, 2015, Journal of pediatric hematology/oncology.

Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.

A. King, M. Pulsipher, E. Angelucci, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early outcomes after allogeneic hematopoietic SCT in pediatric patients with hematologic malignancies following single fraction TBI

T. Druley, K. Trinkaus, D. Adkins, 2009, Bone Marrow Transplantation.

T. Howard, D. Brennan, D. Hagerty, 1996, Surgery.

Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy.

M. Bar, J. Wagner, J. Sierra, 2021, Transplantation and cellular therapy.

Changes in liver core temperature during preservation and rewarming in human and porcine liver allografts.

T. Howard, S. Strasberg, S. Shenoy, 1996, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Serological evidence of past hepatitis B infection in liver donor and hepatitis B infection in liver allograft

T. Howard, D. Brennan, M. Peters, 1995, The Lancet.

Evidence-based Focused Review Evidence-based Focused Review of the Status of Hematopoietic Stem Cell Transplantation as Treatment of Sickle Cell Disease and Thalassemia Literature Search Strategy

A. King, S. Shenoy, 2022 .

Successful Treatment of Multisystem Langerhans Cell Histiocytosis (Histiocytosis X) with Etoposide

S. Shenoy, Lolie C. Yu, R. Warrier, 1994, The American journal of pediatric hematology/oncology.

Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma‐to‐red blood cell exchange transfusion

E. Uhlmann, L. Goodnough, S. Shenoy, 2013, Transfusion.

Hydroxychloroquine for the prevention of acute graft-versus-host disease after unrelated donor transplantation.

R. Vij, K. Trinkaus, H. McLeod, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

T γ/δ hepatosplenic lymphoma in a heart transplant patient after an epstein‐barr virus positive lymphoproliferative disorder

Z. Kaleem, D. Crawford, C. MacArthur, 1998, Cancer.

Benefits of newborn screening and hematopoietic cell transplant in infantile Krabbe disease

J. Kurtzberg, Mai‐Lan Ho, Margie A. Ream, 2022, Blood advances.

Operative injury to the hepatic artery.

T. Howard, S. Shenoy, J. Lowell, 1996, Archives of surgery.

Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group.

M. Loh, S. Grupp, C. Bollard, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens.

S. Davies, P. Mehta, M. Cairo, 2014, Blood.

Stem cell transplantation in genetically linked regulatory T-cell disorders.

S. Shenoy, 2008, Chemical immunology and allergy.

S. Shenoy, Alexander Ngwube, 2018 .

Familial Haploidentical Stem Cell Transplant in Children and Adolescents With High-Risk Sickle Cell Disease: A Phase 2 Clinical Trial.

M. Cairo, B. Grossman, Q. Shi, 2019, JAMA pediatrics.

Reduced Intensity Unrelated Umbilical Cord Blood Transplantation for Sickle Cell Disease: Results of a Phase I Trial

D. Jacobsohn, S. Shenoy, David C. Delgado, 2017 .

K. Leung, M. Horowitz, J. Panepinto, 2016, Blood.

A. Thompson, S. Shenoy, 2016, Annals of the New York Academy of Sciences.

Allogeneic peripheral blood stem cell transplantation following CD34+ enrichment by density gradient separation

R. Vij, J. Dipersio, D. Adkins, 2000, Bone Marrow Transplantation.

Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric Patients.

K. Trinkaus, M. Pulsipher, J. Bednarski, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey

L. Notarangelo, J. Walter, J. Puck, 2020, Frontiers in Immunology.

Granulocyte Colony-Stimulating Factor is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease.

G. Cuvelier, M. Andreánsky, M. Bhatia, 2021, Transplantation and cellular therapy.

Excellent Overall Survival and Low Incidence of Late Effects in Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Sickle Cell Disease: A Report from the Center for International Blood and Marrow Transplant Research (CIBMTR)

B. Shaw, L. Krishnamurti, R. Phelan, 2019, Blood.

American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation.

J. Wagner, J. Bolaños-Meade, J. Tisdale, 2021, Blood advances.

Significant improvement of child physical and emotional functioning after familial haploidentical stem cell transplant

A. Rodday, S. Braniecki, M. Cairo, 2022, Bone Marrow Transplantation.

Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation

D. Friedman, E. Vichinsky, S. Braniecki, 2021, Bone Marrow Transplantation.

Comment on: Acquired monosomy 7 myelodysplastic syndrome in a child with clinical features of dyskeratosis congenita and IMAGe association

T. Ferkol, M. Bessler, S. Shenoy, 2018, Pediatric blood & cancer.

Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease.

J. Wagner, J. Tisdale, J. Meerpohl, 2020, Blood.

Alemtuzumab based reduced intensity transplantation for pediatric severe aplastic anemia

J. Dalal, S. Shenoy, B. Loechelt, 2015, Pediatric blood & cancer.

Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning Is Successful in Children with Hematologic Cytopenias of Genetic Origin.

S. Shenoy, B. Loechelt, R. Hayashi, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.

J. Wagner, J. Bolaños-Meade, J. Tisdale, 2019, The Lancet. Haematology.

Polymerase chain reaction-triggered preemptive or deferred therapy to control cytomegalovirus-associated morbidity and costs in renal transplant patients.

T. Howard, D. Brennan, G. Storch, 1997, Transplantation proceedings.

A single‐center experience using alemtuzumab, fludarabine, melphalan, and thiotepa as conditioning for transplantation in pediatric patients with chronic granulomatous disease

J. Bednarski, S. Shenoy, S. Bhatt, 2020, Pediatric blood & cancer.

Advances in unrelated and alternative donor hematopoietic cell transplantation for nonmalignant disorders

J. Boelens, S. Shenoy, 2015, Current opinion in pediatrics.

Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT

L. Notarangelo, J. Puck, T. Torgerson, 2019, Journal of Clinical Immunology.

A Comparison of Hematopoietic Cell Transplant Conditioning Regimens for Hemophagocytic Lymphohistiocytosis Disorders.

Michael J. Eckrich, A. Gennery, T. Olson, 2021, The Journal of allergy and clinical immunology.

Organ function indications and potential improvements following curative therapy for sickle cell disease.

S. Shenoy, M. Hulbert, Allison A King, 2022, Hematology. American Society of Hematology. Education Program.

Human Polyomaviruses in Children Undergoing Transplantation, United States, 2008–2010

C. Canter, David Wang, Lori R. Holtz, 2012, Emerging infectious diseases.

Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation.

R. Vij, K. Trinkaus, J. Dipersio, 2003, Blood.

Case Report: “Primary Immunodeficiency”—Severe Autoimmune Enteropathy in a Pediatric Heart Transplant Recipient Treated With Abatacept and Alemtuzumab

M. Cooper, S. Shenoy, D. Mokshagundam, 2022, Frontiers in Immunology.

Long-Term Follow-Up after Reduced-Intensity Conditioning and Stem Cell Transplantation for Childhood Nonmalignant Disorders.

M. Pulsipher, K. Chan, G. Hale, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

P. Hari, W. Tse, M. Horowitz, 2018, Haematologica.

A multicenter report on the safety and efficacy of plerixafor based stem cell mobilization in children with malignant disorders

C. Strahlendorf, J. Stanek, T. O'Brien, 2021, Transfusion.

Characterization of HCV‐Specific CD4+Th17 Immunity in Recurrent Hepatitis C–Induced Liver Allograft Fibrosis

T. Mohanakumar, S. Shenoy, H. I. Basha, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Isolated Extramedullary Relapse of Pediatric Leukemia Following Stem Cell Transplantation : A Single Center Review

Y. Barnes, S. Shenoy, R. Hayashi, 2014 .

A randomized double-blind trial of hydroxychloroquine for the prevention of chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.

R. Vij, M. Tomasson, K. Trinkaus, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Menin Inhibitor SNDX-5613 (revumenib) Leads to Durable Responses in Patients (Pts) with KMT2A-Rearranged or NPM1 Mutant AML: Updated Results of a Phase (Ph) 1 Study

J. Dipersio, N. Shukla, I. Aldoss, 2022, Blood.

Long-term organ function after HCT for SCD: a report from the Sickle cell Transplant Advocacy and Research alliance.

Yijin Xiang, L. Krishnamurti, J. Kanter, 2022, Transplantation and cellular therapy.

Children's Mercy Kansas City

B. George, V. Mathews, C. Dvorak, 2020 .

Early Identification of Barriers and Facilitators to Self-Management Behaviors in Pediatric Patients With Sickle Cell Disease to Minimize Hematopoietic Cell Transplantation Complications

Elizabeth S. Molzon, S. Shenoy, R. Foster, 2018, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

Ofatumumab for a rituximab‐allergic child with chronic‐relapsing paraneoplastic opsoclonus–myoclonus

M. Pranzatelli, S. Shenoy, E. Tate, 2012, Pediatric blood & cancer.

The domino transplant: transplant recipients as organ donors.

T. Howard, D. Brennan, G. Singer, 2000, Transplantation.

T Cell Costimulation Blockade with Abatacept Nearly Eliminates Early Severe Acute Graft Versus Host Disease after HLA-Mismatched (7/8 HLA Matched) Unrelated Donor Transplant, with a Favorable Impact on Disease-Free and Overall Survival

M. Norkin, M. Pasquini, S. Choi, 2017 .

Unusual presentations of nonmycotic hepatic artery pseudoaneurysms after liver transplantation.

C. Coopersmith, T. Howard, S. Shenoy, 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Resolution of CGD Related Colitis after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Granulomatous Disease—Early Results From the 6903 Study of the Primary Immune Deficiency Treatment Consortium (PIDTC)

L. Notarangelo, J. Puck, K. Sullivan, 2018 .

Transplant recipients as organ donors: the domino transplant.

T. Howard, D. Brennan, G. Singer, 1997, Transplantation proceedings.

Genetic and Molecular Genetic Studies in the Diagnosis of Atypical Lymphoid Hyperplasias Versus Lymphoma

S. Shenoy, M. Kraus, J. Melnick, 2003 .

ABO‐incompatible organ transplantation

T. Mohanakumar, S. Shenoy, V. Subramanian, 2012, International journal of immunogenetics.

A RANDOMIZED, DOUBLE-BLINDED COMPARISON OF THYMOGLOBULIN VS ATGAM FOR INDUCTION IN ADULT RENAL TRANSPLANT RECIPIENTS

M. Schnitzler, T. Howard, D. Brennan, 1998 .

Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome.

T. Chatila, S. Arnold, S. Shenoy, 2000, The Journal of pediatrics.

Successful Orthotopic Liver Transplantation in an Adult Patient with Sickle Cell Disease and Review of the Literature

W. Chapman, M. Lisker‐Melman, S. Shenoy, 2013, Hematology reports.

A Phase 2 Trial of KIR Mismatched Unrelated Donor Transplantation Using In Vivo T-cell Depletion with ATG in AML: Children's Oncology Group AAML05P1 Study.

S. Meshinchi, T. Alonzo, R. Gerbing, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018).

L. Notarangelo, J. Puck, T. Torgerson, 2019, The Journal of allergy and clinical immunology.

The role of liver transplantation for hepatic adenomatosis in the pediatric population: Case report and review of the literature

R. Shepherd, M. Doyle, S. Shenoy, 2010, Pediatric transplantation.

INTERIM ANALYSIS OF A SINGLE-CENTER, PROSPECTIVE, RANDOMIZED TRIAL COMPARING TACROLIMUS VERSUS CYCLOSPORINE IMMUNOSUPPRESSION USING 2 HOUR POST DOSE (C2) MONITORING IN DE NOVO LIVER TRANSPLANT RECIPIENTS

W. Chapman, M. Lisker‐Melman, S. Shenoy, 2004 .

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia

S. Armstrong, J. Dipersio, N. Shukla, 2023, Nature.

Liver transplantation after jejunoileal bypass for morbid obesity.

T. Howard, M. Peters, C. Caldwell, 1997, Journal of the American College of Surgeons.

Can defibrotide prophylaxis prevent sinusoidal obstruction syndrome following haematopoietic stem-cell transplantation?

S. Shenoy, N. Shah, 2023, The Lancet. Haematology.

T. Howard, D. Brennan, M. W. Flye, 1995, Transplantation.

Children's Oncology Group's 2023 blueprint for research: Cellular therapy and stem cell transplantation

J. Chewning, C. Bollard, T. Fry, 2023, Pediatric blood & cancer.

CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease

S. Shenoy, H. Rangarajan, Alison S. Towerman, 2022, Bone Marrow Transplantation.

T Cell Costimulation Blockade with CTLA4-Ig (Abatacept) for Acute Gvhd Prevention in HLA Matched and Mismatched Unrelated Donor Transplantation: Results of the First Phase 2 Trial

M. Norkin, M. Pasquini, M. Tighiouart, 2019, Biology of Blood and Marrow Transplantation.

Long-term results with the Kasai operation for biliary atresia.

T. Howard, S. Shenoy, J. Lowell, 1996, Archives of surgery.

Atrial laceration caused by removal of a transjugular intrahepatic portosystemic shunt necessitates emergent cardiopulmonary bypass during liver transplant: a case report.

W. Chapman, M. Doyle, S. Shenoy, 2011, Transplantation proceedings.

Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium

L. Notarangelo, J. Puck, T. Torgerson, 2023, The Lancet.

Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek™), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial

C. Pui, H. Kantarjian, S. Jeha, 2005, Leukemia.

154: Allogeneic transplantation for Wiskott Aldrich Syndrome using a reduced intensity conditioning regimen

Y. Barnes, S. Shenoy, R. Hayashi, 2007 .

Mixed donor chimerism following stem cell transplantation for sickle cell disease

S. Shenoy, H. Rangarajan, Alexander Ngwube, 2023, Current opinion in hematology.

Clinical Outcomes and Long-Term Follow-up of Children with Mixed Myeloid Chimerism Following Hematopoietic Cell Transplantation (HCT) for Sickle Cell Disease (SCD)

M. Bhatia, S. Shenoy, G. Guilcher, 2023, Transplantation and Cellular Therapy.

Normalization of Cerebral Hemodynamics after Hematopoietic Stem Cell Transplant in Children with Sickle Cell Anemia

Yasheng Chen, H. An, J. Shimony, 2017 .

Tocilizumab for the Treatment of Steroid Refractory Acute Graft Versus Host Disease: A Pediatric Experience

S. Shenoy, S. Bhatt, Ginny L. Schulz, 2016 .

Higher Abatacept Exposure Decreases Acute GVHD Risk Without Increasing Adverse Events.

D. Neuberg, S. Choi, B. Blazar, 2023, Blood.

Plerixafor Is Highly Effective for the Mobilization of Autologous PBSC for Transplant in Children Failing to Mobilize by Conventional Means: International Experience with 40 Children From 19 Centers

C. Strahlendorf, M. Mohty, M. Ebinger, 2011 .

Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.

E. Neufeld, P. Bierling, J. Bussel, 2012, Blood.

THE EFFECT OF SURGICAL SITE INFECTION ON OUTCOMES IN LIVER TRANSPLANTATION

C. Hollenbeak, M. Schnitzler, T. Howard, 1999 .

A Multicenter Retrospective Analysis Stressing the Importance of Long-Term Follow-Up after Hematopoietic Cell Transplantation for β-Thalassemia.

M. Ayas, A. Thompson, M. Bhatia, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

T. Howard, D. Brennan, S. Shenoy, 1996, Transplantation proceedings.